Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Austria

European Innovation Council · Running

The Angelvalve Project AVVie Advancing Transcatheter Mitral Valve Repair

Coordinator
Avvie GmbH, Austria
Runs
1 February 2023 to 31 January 2025
Status
Running
EU funding
€2.5m
Total cost
€8.7m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190163567

What the project is doing

In the project's own words, from its summary on CORDIS.

The Mitral butterfly implant is a posterior leaflet augmentation device which functions to prevent excessive posterior leaflet motion. The implant comprises a)a Nitinol frame designed to sit comfortably within the anatomy of the heart and to provide the overall structure of the implant,b)an artificial leaflet, in the form of a flexible mesh which serves to restrict the prolapsing leaflet and provide a surface for adequate coaptation, and c)a method of anchoring.

The implant can be folded into a catheter to facilitate delivery and be deployed in the target region with minimal actuation. The shape memory capabilities of nitinol allow the implant to self-expand when released, and the design of the frame ensures the correct orientation within the valve, consequently, the procedure involves minimal actuated steps with the main mechanical complexity arising from the anchorage. The anchorage itself is achieved with a secondary self-expanding nitinol mechanism.

Topics

Who is involved

OrganisationCityCountryRole
Avvie GmbHWienAustriaCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI